182. Manufactured Evidence-The Systematic Fraud Behind Adolescent SSRI Prescribing

Professor Jon Jureidini is a child psychiatrist who leads the Critical and Ethical Mental Health research group at Adelaide University in Australia. His forensic deconstruction of industry-sponsored clinical trials has exposed how pharmaceutical companies manipulate data, employ ghostwriters, and cultivate academic figureheads to create an illusion of scientific consensus around their products. Prof. Jureidini has revealed how medications prescribed to our most vulnerable populations—children and adolescents—gained approval based on studies that were fundamentally misrepresented in the scientific literature. In his groundbreaking book, 'The Illusion of Evidence-Based Medicine: Exposing the crisis of credibility in clinical research,' co-authored with Leemon McHenry, he systematically demonstrates how commercial interests have hijacked the evidence base that clinicians rely on, compromising patient care in the process. His work raises profound questions about the integrity of published research and challenges us to reconsider the foundations of modern medicine. Jureidini reveals shocking findings about the landmark 'Treatment of Adolescent Depression Study (TADS) study that's been used to justify prescribing antidepressants to teenagers—despite evidence showing a five-fold increase in suicidal events. With nearly 20% of adolescent girls now taking SSRIs, this conversation exposes the profit-driven deception that puts millions of developing brains at risk while pharmaceutical companies continue to thrive on what Jureidini calls "the illusion of evidence-based medicineChapters00:00 Introduction to the Crisis in Psychiatry02:20 The Illusion of Evidence-Based Medicine04:34 The TADS Study: A Closer Look10:47 Evaluating the TADS Study's Findings14:22 The Ethics of Informed Consent26:28 Risks and Alternatives in Treatment32:59 The Controversy of Antidepressant Prescriptions35:46 Ethical Concerns in Pharmaceutical Practices40:29 The Impact of Clinical Trials on Drug Approval47:08 Challenges in Psychiatric Research and Publication50:29 Restoring Trust in Scientific Integrity58:20 A Shift Towards Social Determinants of Mental Health